BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33464364)

  • 1. Do antispasmodics or rectal enemas improve image quality on multiparametric prostate MRI? An 'Evidence-Based Practice' review of the literature.
    Brennan DL; Lazarakis S; Lee A; Tan TH; Chin KY; Oon SF
    Abdom Radiol (NY); 2021 Jun; 46(6):2770-2778. PubMed ID: 33464364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal gas-induced susceptibility artefacts on prostate diffusion-weighted MRI with epi read-out at 3.0 T: does a preparatory micro-enema improve image quality?
    Plodeck V; Radosa CG; Hübner HM; Baldus C; Borkowetz A; Thomas C; Kühn JP; Laniado M; Hoffmann RT; Platzek I
    Abdom Radiol (NY); 2020 Dec; 45(12):4244-4251. PubMed ID: 32500236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality.
    Slough RA; Caglic I; Hansen NL; Patterson AJ; Barrett T
    Clin Radiol; 2018 Feb; 73(2):216.e9-216.e14. PubMed ID: 28803622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of bowel preparation techniques for prostate MRI: a preliminary study.
    Schmidt C; Hötker AM; Muehlematter UJ; Burger IA; Donati OF; Barth BK
    Abdom Radiol (NY); 2021 Aug; 46(8):4002-4013. PubMed ID: 33770222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effect of rectal distension on prostate multiparametric MRI image quality.
    Caglic I; Hansen NL; Slough RA; Patterson AJ; Barrett T
    Eur J Radiol; 2017 May; 90():174-180. PubMed ID: 28583630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.
    Ullrich T; Quentin M; Schmaltz AK; Arsov C; Rubbert C; Blondin D; Rabenalt R; Albers P; Antoch G; Schimmöller L
    Eur Radiol; 2018 Jan; 28(1):17-23. PubMed ID: 28687912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
    Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
    Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a cleansing enema improve image quality of 3T surface coil multiparametric prostate MRI?
    Lim C; Quon J; McInnes M; Shabana WM; El-Khodary M; Schieda N
    J Magn Reson Imaging; 2015 Sep; 42(3):689-97. PubMed ID: 25556957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?
    Antunes N; Vas D; Sebastia C; Salvador R; Ribal MJ; Nicolau C
    Abdom Radiol (NY); 2021 Jul; 46(7):3401-3409. PubMed ID: 33683430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal preparation significantly improves prostate imaging quality: Assessment of the PI-QUAL score with visual grading characteristics.
    Arnoldner MA; Polanec SH; Lazar M; Noori Khadjavi S; Clauser P; Pötsch N; Schwarz-Nemec U; Korn S; Hübner N; Shariat SF; Helbich TH; Baltzer PAT
    Eur J Radiol; 2022 Feb; 147():110145. PubMed ID: 35007983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiparametric MRI of the prostate].
    Herrmann J; Kaufmann S; Zhang C; Rausch S; Bedke J; Stenzl A; Nikolaou K; Kruck S; Seith F
    Urologe A; 2022 Apr; 61(4):428-440. PubMed ID: 35389061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
    Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
    Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
    Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient preparation for prostate MRI: A scoping review.
    Prabhakar S; Schieda N
    Eur J Radiol; 2023 May; 162():110758. PubMed ID: 36905717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate MRI and image Quality: It is time to take stock.
    Lin Y; Yilmaz EC; Belue MJ; Turkbey B
    Eur J Radiol; 2023 Apr; 161():110757. PubMed ID: 36870241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
    Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
    Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.
    Alabousi M; Salameh JP; Gusenbauer K; Samoilov L; Jafri A; Yu H; Alabousi A
    BJU Int; 2019 Aug; 124(2):209-220. PubMed ID: 30929292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.
    Lagemaat MW; Philips BW; Vos EK; van Uden MJ; Fütterer JJ; Jenniskens SF; Scheenen TW; Maas MC
    Invest Radiol; 2017 May; 52(5):295-301. PubMed ID: 28002239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.
    Engels RRM; Israël B; Padhani AR; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):457-468. PubMed ID: 31582290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.